What does CUSIP 74623V103 represent in this 13F holders report?

CUSIP 74623V103 is the security identifier for PCT - PureCycle Technologies, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCT - PureCycle Technologies, Inc. - Common Stock in Q2 2021?

109 institutional investors reported PCT - PureCycle Technologies, Inc. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

PureCycle Technologies, Inc. - Common Stock (PCT)

CUSIP: 74623V103

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / Common Stock
Total 13F shares: 46,860,426
Total 13F value: $1,107,953,680
Share change: +15,541,423
Put/Call ratio: 67%
SEC-reported price per share: $23.65
Number of holders: 109
Value change: +$362,189,963
Number of buys: 82
Number of sells: 46
Shares outstanding: 180,820,812

Security key

74623V103

Report period

Q2 2021

Institutions

109

Top holders

PCT full security history Ownership snapshot Full 13F holder table PureCycle Technologies, Inc. SEC filings PureCycle Technologies, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PCT - PureCycle Technologies, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Sylebra Capital Ltd

Disclosed value leader

Sylebra Capital Ltd

Comparable rows

15/15

Latest evidence

31 Mar 2021

13F Lead comparable stake: 9.5% Showing 1-6 of 15 holder rows.

Quick read

Sylebra Capital Ltd leads the comparable SEC ownership view at 9.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sylebra Capital Ltd's linked filing trail.

Comparable ownership Top 5

Sylebra Capital Ltd 9.5%

SAMLYN CAPITAL, LLC 1.8%

Hughes Medical Institute Howard 0.92%

HARVARD MANAGEMENT CO INC 0.71%

Legacy Advisors, LLC 0.59%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Sylebra Capital Ltd	13F Company 13F	9.5%	$438,151,000 17,182,391 shares	—	31 Mar 2021
SAMLYN CAPITAL, LLC	13F Company 13F	1.8%	$83,804,000 3,286,433 shares	—	31 Mar 2021
Hughes Medical Institute Howard	13F Individual 13F	0.92%	$42,475,000 1,665,694 shares	—	31 Mar 2021
HARVARD MANAGEMENT CO INC	13F Company 13F	0.71%	$32,545,000 1,276,267 shares	—	31 Mar 2021
Legacy Advisors, LLC	13F Company 13F	0.59%	$27,229,000 1,067,800 shares	—	31 Mar 2021
Jefferies Group LLC	13F Company 13F	0.54%	$24,834,909 973,918 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

109

46,860,426

Rows available

109

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

109

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q2 2021 value	Value change	Value Chg %